A 844606 - CAS 861119-08-6
Category: Inhibitor
Please be kindly noted products are not for therapeutic use. We do not sell to patients.
Molecular Formula:
C20H20N2O2
Molecular Weight:
320.38
COA:
Inquire
Targets:
nAChR
Description:
A 844606 is a selective α7 nicotinic acetylcholine receptor (nAChR) partial agonist (EC50 = 1.4 and 2.2 μM at human and rat receptors, respectively). It has no measurable effect on α4β2 nAChRs.
Brife Description:
α7 nAChR partial agonist
Purity:
≥99% by HPLC
Synonyms:
2-(Hexahydro-5-methylpyrrolo[3,4-c]pyrrol-2(1H)-yl)-9H-xanthen-9-one
MSDS:
Inquire
InChIKey:
WUJHMDPPANTBTQ-UHFFFAOYSA-N
InChI:
InChI=1S/C20H20N2O2/c1-21-9-13-11-22(12-14(13)10-21)15-6-7-19-17(8-15)20(23)16-4-2-3-5-18(16)24-19/h2-8,13-14H,9-12H2,1H3
Canonical SMILES:
CN1CC2CN(CC2C1)C3=CC4=C(C=C3)OC5=CC=CC=C5C4=O
1.Characterization of [(3)H]CHIBA-1001 binding to alpha7 nicotinic acetylcholine receptors in the brain from rat, monkey, and human.
Tanibuchi Y;Wu J;Toyohara J;Fujita Y;Iyo M;Hashimoto K Brain Res. 2010 Aug 12;1348:200-8. doi: 10.1016/j.brainres.2010.06.008. Epub 2010 Jun 9.
Accumulating evidence suggests that the alpha7 subtype of nicotinic acetylcholine receptors (nAChRs) plays a role in the pathophysiology of neuropsychiatric diseases, including schizophrenia and Alzheimer's disease. Currently, there are no suitable small molecule radioligands for alpha7 nAChRs in the brain, although [(125)I]alpha-bungarotoxin has been widely used as a radioligand for alpha7 nAChRs. In the present study, we characterized a new radioligand, 4-[(3)H]methylphenyl 2,5-diazabicyclo[3.2.2]nonane-2-carboxylate ([(3)H]CHIBA-1001), a derivative of the selective alpha7 nAChR agonist SSR180711, in brain membranes from rat, monkey, and human. Scatchard analysis revealed an apparent equilibrium dissociation constant (Kd) of 193.4nM in rat brain membranes at 4 degrees C, and the maximal number of binding sites (Bmax) was 346.2fmol/mg protein. The order of drugs for the inhibition of [(3)H]CHIBA-1001 binding to rat brain membranes is SSR180711>A-844606>MG624>epibatidine>DMAB>A-582941, suggesting a similarity of alpha7 nAChR pharmacological profiles. In contrast, alpha-bungarotoxin, MLA, and nicotine were found to be very weak. The distribution of [(3)H]CHIBA-1001 binding to crude membranes from dissected regions of rat, monkey, and human brain was different from that of [(125)I]alpha-bungarotoxin binding, suggesting that [(3)H]CHIBA-1001 binding sites may not be identical to [(125)I]alpha-bungarotoxin binding in the brain.
2.alpha7 nicotinic acetylcholine receptor agonist properties of tilorone and related tricyclic analogues.
Briggs CA;Schrimpf MR;Anderson DJ;Gubbins EJ;Grønlien JH;Håkerud M;Ween H;Thorin-Hagene K;Malysz J;Li J;Bunnelle WH;Gopalakrishnan M;Meyer MD Br J Pharmacol. 2008 Mar;153(5):1054-61. Epub 2007 Dec 24.
BACKGROUND AND PURPOSE: ;The alpha7 nicotinic acetylcholine receptor (nAChR) has attracted considerable interest as a target for cognitive enhancement in schizophrenia and Alzheimer's Disease. However, most recently described alpha7 agonists are derived from the quinuclidine structural class. Alternatively, the present study identifies tilorone as a novel alpha7-selective agonist and characterizes analogues developed from this lead.;EXPERIMENTAL APPROACH: ;Activity and selectivity were determined from rat brain alpha7 and alpha4beta2 nAChR binding, recombinant nAChR activation, and native alpha7 nAChR mediated stimulation of ERK1/2 phosphorylation in PC12 cells.;KEY RESULTS: ;Tilorone bound alpha7 nAChR (IC(50) 110 nM) with high selectivity relative to alpha4beta2 (IC(50) 70 000 nM), activated human alpha7 nAChR with an EC(50) value of 2.5 microM and maximal response of 67% relative to acetylcholine, and showed little agonist effect at human alpha3beta4 or alpha4beta2 nAChRs. However, the rat alpha7 nAChR maximal response was only 34%. Lead optimization led to 2-(5-methyl-hexahydro-pyrrolo[3,4-c]pyrrol-2-yl)-xanthen-9-one (A-844606) with improved binding (alpha7 IC(50) 11 nM, alpha4beta2 IC(50)>30 000 nM) and activity at both human and rat alpha7 nAChR (EC(50)s 1.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related nAChR Products


CAS 200432-86-6 UB 165 fumarate

UB 165 fumarate
(CAS: 200432-86-6)

UB 165 fumarate is a full agonist at α3β2- and a weak partial agonist at α4β2- containing nAChRs (Ki = 0.27, 20 (IC50), 2790 and 990 nM for α4β2, α3, α7 and α1β...

CAS 304679-75-2 S 24795

S 24795
(CAS: 304679-75-2)

S 24795 is a partial agonist of α7 nAChR with memory-enhancing activity. S 24795 improves mnemonic function in aged mice for the treatment of aging-related memo...

CAS 492-02-4 CC4

CC4
(CAS: 492-02-4)

CC4 is a selective α6β2 and α4β2 nAChR partial agonist (Ki = 12 and 26nM for rat α6β2 and α4β2 receptors, respectively). CC4 stimulates dopamine release from st...

AZD 0328
(CAS: 220099-91-2)

AZD 0328 is a potent α7 NNR/5HT3 receptor agonist. AZD0328 led to a significant increase in cortical dopamine release in awake rodents and improved both conditi...

CAS 55-97-0 Hexamethonium Bromide

Hexamethonium Bromide
(CAS: 55-97-0)

Hexamethonium Bromide is a selective antagonist of neuronal-type nicotinic AChR in ganglia.

CAS 216853-60-0 NS 3861

NS 3861
(CAS: 216853-60-0)

NS 3861 is an α3β2 full agonist with EC50 of 1.6 μM. It is also an α3β4 partial agonist with EC50 of 1 μM.

CAS 77257-42-2 MG 624

MG 624
(CAS: 77257-42-2)

MG624 is a neuronal nicotinic acetylcholine receptors antagonist. It is selective for neuronal nAChRs over muscle-type AChRs. It can decrease vagus nerve stimul...

CAS 72420-38-3 Acifran

Acifran
(CAS: 72420-38-3)

Acifran is a nicotinic acid receptor agonist with hypolipidemic effects, which shows higher potency than nicotinic acid and clofibrate. It is a potent and full ...

Chemical Structure

CAS 861119-08-6 A 844606

Quick Inquiry

Verification code

Featured Items